Genetic Counseling for Inherited Disorders
What You Need to Know Before You Apply
What is the purpose of this trial?
The trial aims to improve genetic counseling by exploring methods to enhance patient experiences. Participants will complete two surveys and allow audio recordings of their genetic counseling sessions. The study focuses on benefiting underserved communities, including Somali, Latino/Hispanic, Black/African American, and Hmong groups. Potential participants include those referred to genetic counseling for hereditary cancer, heart conditions, or reproductive issues, who can communicate in English. The trial includes the GC-PRO Intervention, designed to enhance the genetic counseling process. As an unphased trial, it offers participants the opportunity to contribute to improving genetic counseling methods for diverse communities.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It seems unlikely that you would need to stop, as the study focuses on genetic counseling rather than medication use.
What prior data suggests that this genetic counseling method is safe?
Research has shown that genetic counseling is generally safe. Most studies have found it helps people understand their genetic risks without causing harm. A few negative outcomes have occurred, typically when unqualified individuals provide the counseling. When trained professionals conduct genetic counseling, it is usually well-received. Participants in past studies did not report any major problems. Therefore, if considering joining a study that includes genetic counseling, the risks are usually low.12345
Why are researchers excited about this trial?
Researchers are excited about the GC-PRO intervention because it offers a fresh approach to genetic counseling for inherited disorders. Unlike traditional methods that may involve basic counseling at diagnosis, this intervention emphasizes a structured and timed transition from standard care to comprehensive genetic counseling over specific intervals. This allows for more personalized and targeted support throughout the patient's journey. The hope is that this tailored approach will lead to better understanding and management of the condition, empowering patients with critical knowledge about their genetic risks and options.
What evidence suggests that this trial's genetic counseling methods could be effective?
Research has shown that genetic counseling can greatly improve patient outcomes. Studies have found that it enhances patient experiences, reduces worry, and increases understanding of inherited disorders. In this trial, participants will be randomized into different clusters to transition from standard care to genetic counseling at various times. These benefits appear in people from various backgrounds, making genetic counseling a promising option for many. Effective communication plays a key role in these positive results. Overall, genetic counseling has demonstrated clear benefits for those dealing with inherited disorders.12346
Who Is on the Research Team?
Heather Zierhut
Principal Investigator
University of Minnesota
Are You a Good Fit for This Trial?
The GC-PRO study is for adults 18 or older who, or whose child, have been referred for genetic counseling due to a family/personal history of hereditary cancer, heart issues, general genetic conditions, or reproductive concerns. Participants must understand English to complete forms and surveys.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Genetic Counseling Intervention
Participants receive genetic counseling and complete two surveys, with audio recording of the session
Follow-up
Participants are monitored for outcomes such as patient empowerment, activation, and perception of genetic counseling quality
What Are the Treatments Tested in This Trial?
Interventions
- GC-PRO Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Minnesota
Lead Sponsor
University of South Florida
Collaborator